Sept 2026 Quarterly Activities Report and Appendix 4C
Filed with ASX ·
6ix is reading this filing.
Earlier from Racura Oncology
- HARNESS-1 First Cohort Cleared
- CPACS Trial Opens for RC220 Patient Enrolment in Korea
- First HARNESS-1 Patient Safely Treated with RC220
- June 2026 Quarterly Activities Report and Appendix 4C
- Bellberry Ethics Approval Activates New HARNESS Trial Sites
Follow Racura Oncology into a list and get an email when it puts out news.
Follow Racura Oncology